News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
ESTRO – To Escalate or to De-Escalate Radiation Dose in Stage 3 NSCLC?
Photo taken from ESTRO/LinkedIn
Jul 25, 2024, 23:48

ESTRO – To Escalate or to De-Escalate Radiation Dose in Stage 3 NSCLC?

European Society for Radiotherapy and Oncology shared on LinkedIn:

“Key insights from ESTRO24 on the optimisation of radiation doses for stage III NSCLC in the era of immunotherapy and tyrosine kinase inhibitors. Learn about dose escalation trials, individualised treatment strategies, and the role of biomarkers in the guidance of therapy.”

Read further.
Source: European Society for Radiotherapy and Oncology/LinkedIn

cancer ESTRO24 European SocieTy for Radiotherapy and Oncology NSCLC OncoDaily Oncology
Special Coverage
Science
Feb 21, 2025, 10:07
Elai Davicioni: Predicting Dose-Response to Prostate Cancer Radiotherapy
Blog
Feb 21, 2025, 10:00
Alexios Matikas: Adjuvant endocrine treatment strategies for non-metastatic breast cancer
Blog
Feb 21, 2025, 09:58
Miriam Mutebi: February - a whirlwind of learning, collaboration, and action
Blog
Feb 21, 2025, 09:54
The publication of the European Commission Work Programme for 2025 - ESMO
Blog
Feb 21, 2025, 09:45
Michelle Kirschner: New programming at the Cancer Survivorship Provider Network
Science
Feb 21, 2025, 09:39
M. Bilal Abid: Excited to present at the UT San Antonio MD Anderson Cancer Center
Blog
Feb 21, 2025, 09:35
UICC is seeking an Executive Director to lead the ATOM Coalition in Geneva
Blog
Feb 21, 2025, 09:18
Belén Garijo: A very important evolution of Merck Group's Executive Board
Blog
Feb 21, 2025, 09:07
Karen Knudsen: Integrating technology into clinical practice
Blog
Feb 21, 2025, 09:00
ICCD 2025 Event Highlights: Speakers’ Quote Series - SIOP Europe
Blog
Feb 21, 2025, 08:48
Emily Drake: Delivery of palliative and end-of-life care for AYAs living with cancer
Blog
Feb 21, 2025, 08:19
Chibuike Okafor: How Amgen Defeated the ‘Undruggable’ KRAS